Corticosteroids: the drugs to beat

Area of Science:

• Molecular Biology
• Immunology
• Pharmacology

Background:

• Corticosteroids are primary anti-inflammatory agents for chronic immune and inflammatory diseases like asthma.
• Inflammation involves increased expression of inflammatory genes regulated by transcription factors.
• These factors activate coactivators, leading to histone acetylation and gene transcription.

Purpose of the Study:

• To elucidate the molecular mechanisms of corticosteroid action in suppressing inflammation.
• To investigate the role of histone acetylation and deacetylation in corticosteroid efficacy.
• To understand the basis of steroid resistance in certain inflammatory conditions.

Main Methods:

• Analysis of molecular mechanisms of corticosteroid suppression of inflammatory genes.
• Investigation of glucocorticoid receptor (GR) binding to coactivators and recruitment of histone deacetylase-2 (HDAC2).
• Examination of GR interactions with gene promoters to modulate transcription.

Main Results:

• Corticosteroids reverse histone acetylation of inflammatory genes via GR-mediated HDAC2 recruitment.
• Activated GRs can also induce anti-inflammatory protein transcription.
• Impaired HDAC2 due to oxidative stress in COPD and smoking asthmatics leads to corticosteroid resistance.

Conclusions:

• Corticosteroids exert anti-inflammatory effects by modulating histone acetylation through the GR-HDAC2 complex.
• Abnormalities in GR signaling and impaired HDAC2 function contribute to steroid-resistant asthma and COPD.
• Future therapies may focus on overcoming corticosteroid insensitivity in these conditions.